Digital Marketing Trends in Inflammatory Bowel Disease

Pages: 36 Published: March 31, 2022 Report Code: GDHCHT317

The digital marketing trends in inflammatory bowel disease report analyses key digital marketing metrics of pharma assets in inflammatory bowel disease (IBD), including branded websites for patients and healthcare professionals (HCPs), mobile apps, and social media accounts.

What are the major US patient branded websites of bowel disease?

The major US patient branded websites of Bowel disease are AbbVie’s Humira.com, Takeda’s Entyvio.com, Pfizer’s Xeljanz.com, Janssen’s Stelarainfo.com, Janssen’s Remicade.com, UCB’s Cimzia.com, and Janssen’s Simponi.com. AbbVie achieved the highest total traffic across IBD patient sites in the US for its Humira.com.

Bowel disease digital marketing trends, by US patient branded websites

Bowel disease digital marketing trends, by US patient branded websites

For more US patient branded website insights, download a free sample

What are the major US HCP branded websites of bowel disease?

The major US HCP branded websites of bowel disease are Stelarahcp.com, Entyviohcp.com, Humirapro.com, Cimziahcp.com, and Remicadehcp.com. Humirapro.com had the highest number of total visitors among top IBD websites for HCPs in the US.

Bowel disease digital marketing trends, by US HCP branded websites

Bowel disease digital marketing trends, by US HCP branded websites

For more major US HCP branded website insights, download a free sample

What are the major EUCAN patient and HCP branded websites of bowel disease?

The major EUCAN patient and HCP branded websites of bowel disease are Abbviecare.es, Abbvie-care.de, Abbviecare.ca, Abbviecare.fr, and Takeda-gastroenterologie.de. Abbvie-care.es had the highest pages per visit, while AbbViecare.ca had the lowest bounce rate.

Bowel disease digital marketing trends, by EUCAN patient and HCP branded websites

Bowel disease digital marketing trends, by EUCAN patient and HCP branded websites

For more major EUCAN patient and HCP branded website insights, download a free sample

Who are the key digital marketing players in the inflammatory bowel disease market?

The key digital marketing players in the inflammatory bowel disease market are AbbVie, Janssen, UCB, Pfizer, Takeda, and Merck & Co. AbbVie’s Humira.com achieved the highest total traffic across inflammatory bowel disease (IBD) patient sites in the US, followed by followed by Pfizer’s Xeljanz.com and Janssen’s Stelarainfo.com.

Market overview

Major US patient branded websites AbbVie’s Humira.com, Takeda’s Entyvio.com, Pfizer’s Xeljanz.com, Janssen’s Stelarainfo.com, Janssen’s Remicade.com, UCB’s Cimzia.com, and Janssen’s Simponi.com
Major EUCAN patient and hcp branded websites Abbviecare.es, Abbvie-care.de, Abbviecare.ca, Abbviecare.fr, and Takeda-gastroenterologie.de
Major US HCP branded websites Stelarahcp.com, Entyviohcp.com, Humirapro.com, Cimziahcp.com, and Remicadehcp.com
Key digital marketing players AbbVie, Janssen, UCB, Pfizer, Takeda, and Merck & Co

Scope

  • This report assesses key digital marketing metrics of pharma assets in inflammatory bowel disease (IBD), including branded websites for patients and healthcare professionals (HCPs), mobile apps, and social media accounts.
  • Metrics include website traffic volume, engagement, and source, digital display advertising (DDA), paid search engine optimization (SEO), mobile app downloads, and social media post interaction.
  • Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).

Reasons to Buy

  • Understand the digital marketing competitive landscape in IBD, with a view of leading patient and HCP branded assets across different regions.
  • See what tactics pharma companies are using to drive traffic to their IBD branded assets for patient and HCPs, such as DDA and paid SEO.
  • Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
  • Compare top branded assets for patients y how they address and support different patient needs.
  • See what pharma social media accounts in IBD are the most active and achieving the most engagement.
  • See leading mobile app offerings in IBD from pharma across different regions.

Key Players

AbbVie
Janssen
UCB
Pfizer
Takeda
Merck & Co

Table of Contents

Executive Summary

US Patient Branded Websites

US HCP Branded Websites

US Digital Display Advertising and Search Engine Optimization

US Mobile Apps and Social Media

EUCAN Branded Websites

EUCAN Mobile Apps and Social Media

Appendix

Methodology

About the Authors

Contact Us

Frequently Asked Questions

AbbVie’s Humira.com, Takeda’s Entyvio.com, Pfizer’s Xeljanz.com, Janssen’s Stelarainfo.com, Janssen’s Remicade.com, UCB’s Cimzia.com, and Janssen’s Simponi.com are the major US patient branded websites of bowel disease.

Stelarahcp.com, Entyviohcp.com, Humirapro.com, Cimziahcp.com, and Remicadehcp.com are the major US HCP branded websites of bowel disease.

Abbviecare.es, Abbvie-care.de, Abbviecare.ca, Abbviecare.fr, and Takeda-gastroenterologie.de are the major EUCAN patient and HCP branded websites of bowel disease.

AbbVie, Janssen, UCB, Pfizer, Takeda, and Merck & Co are the key digital marketing players in the inflammatory bowel disease market.

$1,950

Can be used by individual purchaser only

$3,900

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

Still undecided about purchasing this report?

Enquire Before Buying

Request a Free Sample

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods